ViroGates A/S (CPH:VIRO)
Denmark
· Delayed Price · Currency is DKK 8.22
+0.72 (9.60%)
Apr 1, 2025, 1:18 PM CET
ViroGates Revenue
In the year 2024, ViroGates had annual revenue of 7.14M DKK with 2.22% growth. ViroGates had revenue of 1.57M in the quarter ending December 31, 2024, a decrease of -6.33%.
Revenue
7.14M
Revenue Growth
+2.22%
P/S Ratio
7.67
Revenue / Employee
714.20K
Employees
10
Market Cap
63.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.14M | 155.00K | 2.22% |
| Dec 31, 2023 | 6.99M | -8.21M | -54.02% |
| Dec 31, 2022 | 15.20M | 6.95M | 84.27% |
| Dec 31, 2021 | 8.25M | 2.89M | 54.03% |
| Dec 31, 2020 | 5.35M | 1.77M | 49.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 290.40B |
| Coloplast | 27.45B |
| Genmab | 21.53B |
| Demant | 22.42B |
| Zealand Pharma | 62.69M |
| H. Lundbeck | 22.00B |
| Ambu A/S | 5.65B |
| ALK-Abelló | 5.54B |